- William Raveis Charitable Fund and Damon Runyon Cancer Research forge partnership. Bill Raveis (Chariman & CEO, William Raveis Real Estate), Meghan Raveis (Managing Director, William Raveis Charitable Fund), Lorraine Egan (President and CEO, Damon Runyon Cancer Research Foundation) and Alan Leventhal (Chairman, Damon Runyon Board of Directors, Chairman and CEO Beacon Capital Partners, Boston MA).
Damon Runyon Partnership
The William Raveis Charitable Fund has made a major expansion of its mission to include supporting cutting-edge research against all forms of cancer, in addition to assisting cancer patients and their families during treatment.
The Charitable Fund has chosen to partner with the prestigious Damon Runyon Cancer Research Foundation, an industry-leading organization that identifies the most brilliant, creative and passionate young cancer researchers, and provides them with funding to pursue their boldest ideas in search of innovative new ways to prevent, diagnose and treat all forms of cancer. Since 1946, Damon Runyon has invested over $287 million in the best young minds in the nation. Their alumni include 12 Nobel Laureates and leaders of major cancer centers across the United States. Many of their more than 3,460 scientists have gone on to make breakthroughs in the way we prevent, diagnose and treat many forms of cancer. Additionally, 100% donations to the Damon Runyon Cancer Research Foundation fund cancer research.
The William Raveis Charitable Fund is planning a series of community events throughout the Northeast to raise awareness about the importance of cancer research and funds for Damon Runyon.